氯法拉滨; 2-氯-9-(2-脱氧-2-氟-β-D-呋喃阿拉伯糖基)腺嘌呤; 2-氯-9-(2-去氧-2-氟-bata-D-阿拉伯呋喃)-9H-嘌呤-6-胺; 克罗拉宾; 克罗他滨; 氯伐他滨; 氯法拉宾; 克罗拉滨; 2-氯-9-(2-去氧-2-氟-β-D-阿拉伯呋喃)-9H-嘌呤-6-胺; 氯法拉滨(克罗拉滨);
Clofarex; (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; (2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxyméthyl)tétrahydrofuran-3-ol; 9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-; 2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine; (2R,3R,4S,5R)-5-(6-Amino-2-chlor-9H-purin-9-yl)-4-fluor-2-(hydroxymethyl)tetrahydrofuran-3-ol; (2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol; 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine; Cl-F-Ara-A; Clofarabine; Clofarabine [USAN]; Clolar; 2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purin-6-amine; MFCD00871077; 5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-CHLORO-2'-ARABINOFLUORO-2'-DEOXYADENOSINE; CAFDA; 2-chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine; 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-9h-purin-6-amin; 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)adenine; 2-Chloro-9-(2-Deoxy-2-Fluoro-β-D-Arabinofuranosyl)-9H-Purin-6-Amine; 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; (2R,4R,5R)-5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol; (2R,3R,4S,5S)-5-(4-amino-6-chloro-1H-benzo[d]imidazol-1-yl)-4-fluoro-2-(hydroxymethyl)-tetrahydrofuran-3-ol
库房低温通风干燥
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:3 3.氢键受体数量:8 4.可旋转化学键数量:2 5.互变异构体数量:3 6.拓扑分子极性表面积119 7.重原子数量:20 8.表面电荷:0 9.复杂度:370 10.同位素原子数量:0 11.确定原子立构中心数量:4 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1
1.性状:灰白色粉末状固体。